Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS in Adults.
Click here to view original post